blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2111862

EP2111862 - PHARMACEUTICAL PRODUCT FOR PREVENTION AND TREATMENT OF ALZHEIMER'S DEMENTIA [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  05.12.2014
Database last updated on 02.09.2024
Most recent event   Tooltip05.12.2014Application deemed to be withdrawnpublished on 07.01.2015  [2015/02]
Applicant(s)For all designated states
Nagoya City University
1, Aza Kawasumi, Mizuho-cho Mizuho-ku Nagoya-shi
Aichi 467-8601 / JP
For all designated states
Kowa Company, Ltd.
6-29, Nishiki 3-chome Naka-ku
Nagoya-shi, Aichi-ken 460-8625 / JP
[2009/44]
Inventor(s)01 / OJIKA, Kosei
c/o GRADUATE SCHOOL OF MEDICAL SCIENCES NAGOYA CITY UNIVERSITY 1 Aza Kawasumi Mizuho-cho Mizuho-ku
Nagoya-shi Aichi 467-8601 / JP
02 / MATSUKAWA, Noriyuki
c/o GRADUATE SCHOOL OF MEDICAL SCIENCES NAGOYA CITY UNIVERSITY 1 Aza Kawasumi Mizuho-cho Mizuho-ku
Nagoya-shi Aichi 467-8601 / JP
 [2009/44]
Representative(s)Godemeyer Blum Lenze Patentanwälte Partnerschaft mbB - werkpatent
An den Gärten 7
51491 Overath / DE
[N/P]
Former [2013/52]Godemeyer Blum Lenze - werkpatent
An den Gärten 7
51491 Overath / DE
Former [2012/02]Polypatent
An den Gärten 7
51491 Overath / DE
Former [2010/01]Polypatent
Postfach 40 02 43
51410 Bergisch Gladbach / DE
Former [2009/44]Polypatent
An den Gärten 7
51491 Overath / DE
Application number, filing date08702800.722.01.2008
[2009/44]
WO2008JP00059
Priority number, dateJP2007001267123.01.2007         Original published format: JP 2007012671
[2009/44]
Filing languageJA
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2008090736
Date:31.07.2008
Language:JA
[2008/31]
Type: A1 Application with search report 
No.:EP2111862
Date:28.10.2009
Language:EN
[2009/44]
Search report(s)International search report - published on:JP31.07.2008
(Supplementary) European search report - dispatched on:EP16.03.2010
ClassificationIPC:A61K31/445, A61K31/19, A61P25/28, A61P43/00, A61K45/06
[2010/15]
CPC:
A61K31/19 (EP,KR,US); A61K31/445 (EP,KR,US); A61K45/06 (EP,US);
A61P25/28 (EP); A61P43/00 (EP)
C-Set:
A61K31/19, A61K2300/00 (EP,US);
A61K31/445, A61K2300/00 (US,EP)
Former IPC [2009/44]A61K31/445, A61K31/19, A61P25/28, A61P43/00
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2009/44]
TitleGerman:PHARMAZEUTISCHES PRODUKT ZUR VORBEUGUNG UND BEHANDLUNG VON MORBUS ALZHEIMER[2009/44]
English:PHARMACEUTICAL PRODUCT FOR PREVENTION AND TREATMENT OF ALZHEIMER'S DEMENTIA[2009/44]
French:PRODUIT PHARMACEUTIQUE DESTINÉ À LA PRÉVENTION ET AU TRAITEMENT DE LA DÉMENCE D'ALZHEIMER[2009/44]
Entry into regional phase15.07.2009Translation filed 
15.07.2009National basic fee paid 
15.07.2009Search fee paid 
15.07.2009Designation fee(s) paid 
15.07.2009Examination fee paid 
Examination procedure15.07.2009Examination requested  [2009/44]
21.05.2010Amendment by applicant (claims and/or description)
11.11.2011Despatch of a communication from the examining division (Time limit: M04)
04.02.2012Reply to a communication from the examining division
01.08.2014Application deemed to be withdrawn, date of legal effect  [2015/02]
02.09.2014Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time  [2015/02]
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  11.11.2011
Fees paidRenewal fee
13.01.2010Renewal fee patent year 03
14.01.2011Renewal fee patent year 04
25.01.2012Renewal fee patent year 05
10.01.2013Renewal fee patent year 06
Penalty fee
Additional fee for renewal fee
31.01.201407   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[Y]  - BORKOWSKA A ET AL, "P.5.a.005 Possible benefits of valproate addition to donepezil treatment in Alzheimer's disease", EUROPEAN NEUROPSYCHOPHARMACOLOGY, ELSEVIER SCIENCE PUBLISHERS BV, AMSTERDAM, NL, vol. 16, ISSN 0924-977X, (20060101), page S478, (20060101), XP025110615 [Y] 1-7 * the whole document *

DOI:   http://dx.doi.org/10.1016/S0924-977X(06)70636-8
 [Y]  - ROGERS S L ET AL, "Donepezil improves cognition and global function in Alzheimer disease: a 15-week, double-blind, placebo-controlled study. Donepezil Study Group.", ARCHIVES OF INTERNAL MEDICINE, (19980511), vol. 158, no. 9, ISSN 0003-9926, pages 1021 - 1031, XP002571051 [Y] 1-7 * page 1021, column 2, paragraph 2 *
 [A]  - HOLDS W ET AL, "ALZHEIMER'S DISEASE UPDATE: USING WHAT WE NOW KNOW TO HELP PATIENTS", PC CONSULTANT, PTHE NETWORK, OLYMPIA, WA, US, (19990301), vol. 39, no. 3, ISSN 0749-6699, pages 675 - 678,684/6, XP000892762 [A] 1-7 * abstract * * page 684, column 1, paragraph 2 - column 3, paragraph 1 *
International search[Y]JPH10324626  (ONO PHARMACEUTICAL CO)
 [Y]  - TOGO T., "Chiho no Yakubutsu Ryoho", SEISHIN IGAKU, (2004), vol. 46, no. 2, pages 124 - 132, XP008110075
 [Y]  - PROFENNO L. ET AL., "A Randomized, Double-Blind, Placebo-Controlled Pilot Trial of Safety and Tolerability of Two Doses of Divalproex Sodium in Outpatients with Probable Alzheimer's Disease", CURRENT ALZHEIMER RESEARCH, (2005), vol. 2, no. 5, pages 553 - 558, XP008110058

DOI:   http://dx.doi.org/10.2174/156720505774932205
by applicantJPH10324626
    - JOURNAL OF THE JAPAN PHARMACEUTICAL ASSOCIATION, (2006), vol. 58, no. 7, pages 861 - 864
    - N. ENGL. J. MED., (2006), vol. 355, no. 15, page 1525
    - AM. J. GERIATR. PSYCHIATRY, (2005), vol. 13, no. 11, page 942
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.